This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $1250 | Check With Us |
500mg | $1850 | Check With Us |
1g | $2775 | Check With Us |
Cat #: V19624 CAS #: 1616690-16-4 Purity ≥ 98%
Description: Desidustat is an antianaemic drug candidate under investigation for the treatment of anemia of chronic kidney disease. It acts as an inhibitor of HIF hydroxylase. Reference: Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation. Eur J Pharmacol. 2019 Jan 15;843:113-120.
References: [1]. Ranjit C, et al. Novel quinolone derivatives. Patent. WO2014102818A1.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 332.312 |
---|---|
Molecular Formula | C16H16N2O6 |
CAS No. | 1616690-16-4 |
SMILES Code | O=C(O)CNC(C1=C(O)C2=C(N(OCC3CC3)C1=O)C=CC=C2)=O |
Synonyms | Desidustat |
Protocol | In Vivo | Desidustat (oral; 10-100 mg/kg) has good efficacy in vivo. |
---|---|---|
Animal model | C57 Mice | |
Dosages | 10, 30, 50, 100 mg/kg; 20 mg /kg | |
Administration | oral gavage; oral, once, daily, for 7 days |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 3.0092 mL | 15.0461 mL | 30.0922 mL | 60.1844 mL |
5mM | 0.6018 mL | 3.0092 mL | 6.0184 mL | 12.0369 mL |
10mM | 0.3009 mL | 1.5046 mL | 3.0092 mL | 6.0184 mL |
20mM | 0.1505 mL | 0.7523 mL | 1.5046 mL | 3.0092 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.